September 2018, Sanofi agreed to pay $25 million to resolve charges that its subsidiaries in the Middle East and Kazakhstan bribed officials and doctors to boost purchases of its medicines. what Do you think this type of conduct has decreased or increased in recent times?

Answer rating: 100% (QA)

Theres no easy answer to whether foreign bribery by pharmaceutical companies has definitively increa... View the full answer